Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_380Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman cholangiocarcinoma cell lineKMCH-13.0E+3 cells per wellNADojindo cell counting kit0.01 MOI13% cancer cell viability on 7 dayNoNoNA No responseNANANANA26584530
OV_381Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman cholangiocarcinoma cell lineKMC-11.0E+4 cells per wellNADojindo cell counting kit0.01 MOI13% cancer cell viability on 7 dayNoNoNA No responseNANANANA26584530
OV_382Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman cholangiocarcinoma cell lineKMBC1.0E+4 cells per wellNADojindo cell counting kit0.01 MOI90% cancer cell viability on 7 dayNoNoNA No responseNANANANA26584530
OV_383Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman cholangiocarcinoma cell lineKMCH-13.0E+3 cells per wellNADojindo cell counting kit0.1 MOI13% cancer cell viability on 7 dayNoNoNA No responseNANANANA26584530
OV_384Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman cholangiocarcinoma cell lineKMC-11.0E+4 cells per wellNADojindo cell counting kit0.1 MOI13% cancer cell viability on 7 dayNoNoNA No responseNANANANA26584530
OV_385Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman cholangiocarcinoma cell lineKMBC1.0E+4 cells per wellNADojindo cell counting kit0.1 MOI48% cancer cell viability on 7 dayNoNoNA No responseNANANANA26584530
OV_386Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman cholangiocarcinoma cell lineKMCH-13.0E+3 cells per wellNADojindo cell counting kit1 MOI13% cancer cell viability on 7 dayNoNoNA No responseNANANANA26584530
OV_387Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman cholangiocarcinoma cell lineKMC-11.0E+4 cells per wellNADojindo cell counting kit1 MOI13% cancer cell viability on 7 dayNoNoNA No responseNANANANA26584530
OV_388Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman cholangiocarcinoma cell lineKMBC1.0E+4 cells per wellNADojindo cell counting kit1 MOI20% cancer cell viability on 7 dayNoNoNA No responseNANANANA26584530
OV_389Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman cholangiocarcinoma cell lineKMCH-13.0E+3 cells per wellNADojindo cell counting kit5 MOI13% cancer cell viability on 7 dayNoNoNA No responseNANANANA26584530
OV_390Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman cholangiocarcinoma cell lineKMC-11.0E+4 cells per wellNADojindo cell counting kit5 MOI13% cancer cell viability on 7 dayNoNoNA No responseNANANANA26584530
OV_391Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman cholangiocarcinoma cell lineKMBC1.0E+4 cells per wellNADojindo cell counting kit5 MOI20% cancer cell viability on 7 dayNoNoNA No responseNANANANA26584530
OV_392Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoNANANANANANANANAHomozygous athymic female nude mice (subcutaneously injected with KMC-1 cells suspended in 50 μl Matrigel)1.0E+7 PFUNA Reduction in tumor volume to 30 cubic millimeter compared to control 200 cubic millimeter after 15 daysIntratumorallyNANANA26584530
OV_727Vaccinia virusVV-OncoDNAPoxviridaeThe viral thymidine kinase (TK) gene is insertionally inactivatedYesNoNoLiver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, ChinaHuman hepatocellular carcinoma cell lineMHCC97-H5000 to 7000 cells per wellNAMTT assay1 MOI70% cancer cell viability at 96 hours post-infectionNoNoNA No responseNANANANA27441866
OV_728Vaccinia virusVV-OncoDNAPoxviridaeThe viral thymidine kinase (TK) gene is insertionally inactivatedYesNoNoLiver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, ChinaHuman hepatocellular carcinoma cell lineMHCC97-H5000 to 7000 cells per wellNAMTT assay10 MOI50% cancer cell viability at 96 hours post-infectionNoNoNA No responseNANANANA27441866
OV_1907Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCMalignan small cell canine carcinoma cell lineMTH52c1.0E+6 cells per wellNAMTT assay0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNANAVirus cause increase expression of ApoA1, IL-2,11,18,IFN-gamma, IP-10, MCP-1,3,5,MIP-2,MMP-9 and TNF alphaNA20631910
OV_1908Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCMalignan small cell canine carcinoma cell lineMTH52c1.0E+6 cells per wellNAMTT assay0.1 MOI50% cell survival after 48 hoursNoNoNA No responseNANAVirus cause increase expression of ApoA1, IL-2,11,18,IFN-gamma, IP-10, MCP-1,3,5,MIP-2,MMP-9 and TNF alphaNA20631910
OV_1909Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCMalignan small cell canine carcinoma cell lineMTH52c1.0E+6 cells per wellNAMTT assay0.1 MOI30% cell survival after 72 hoursNoNoNA No responseNANAVirus cause increase expression of ApoA1, IL-2,11,18,IFN-gamma, IP-10, MCP-1,3,5,MIP-2,MMP-9 and TNF alphaNA20631910
OV_1910Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCMalignan small cell canine carcinoma cell lineMTH52c1.0E+6 cells per wellNAMTT assay0.1 MOI100% cell death after 96 hoursNoNoNA No responseNANAVirus cause increase expression of ApoA1, IL-2,11,18,IFN-gamma, IP-10, MCP-1,3,5,MIP-2,MMP-9 and TNF alphaNA20631910
OV_1911Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCMalignan small cell canine carcinoma cell lineMTH52c1.0E+6 cells per wellNAMTT assay1 MOI50% cell survival after 24 hoursNoNoNA No responseNANAVirus cause increase expression of ApoA1, IL-2,11,18,IFN-gamma, IP-10, MCP-1,3,5,MIP-2,MMP-9 and TNF alphaNA20631910
OV_1912Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCMalignan small cell canine carcinoma cell lineMTH52c1.0E+6 cells per wellNAMTT assay1 MOI25% cell survival after 48 hoursNoNoNA No responseNANAVirus cause increase expression of ApoA1, IL-2,11,18,IFN-gamma, IP-10, MCP-1,3,5,MIP-2,MMP-9 and TNF alphaNA20631910
OV_1913Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCMalignan small cell canine carcinoma cell lineMTH52c1.0E+6 cells per wellNAMTT assay1 MOI5% cell survival after 72 hoursNoNoNA No responseNANAVirus cause increase expression of ApoA1, IL-2,11,18,IFN-gamma, IP-10, MCP-1,3,5,MIP-2,MMP-9 and TNF alphaNA20631910
OV_1914Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCMalignan small cell canine carcinoma cell lineMTH52c1.0E+6 cells per wellNAMTT assay1 MOI100% cell death after 96 hoursNoNoNA No responseNANAVirus cause increase expression of ApoA1, IL-2,11,18,IFN-gamma, IP-10, MCP-1,3,5,MIP-2,MMP-9 and TNF alphaNA20631910
OV_1915Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCMalignan small cell canine carcinoma cell lineMTH52cNANANANANAHsd athymic nude mice xenograft for MTH52c cell line5.0E+6 pfuNA Significant decrease in tumor volume after 42 daysNANAVirus cause increase expression of ApoA1, IL-2,11,18,IFN-gamma, IP-10, MCP-1,3,5,MIP-2,MMP-9 and TNF alphaNA20631910
OV_2047Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay0.1 MOI50% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2048Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay0.1 MOI20% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2049Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay0.1 MOI20% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2050Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay0.1 MOI22% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2051Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay1 MOI90% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2052Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay1 MOI58% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2053Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay1 MOI30% cell survial after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2054Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay1 MOI22% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2055Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2056Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI80% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2057Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI30% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2058Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI30% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2059Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI80% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2060Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI30% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2061Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI20% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2062Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI20% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2063Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANANANANAAthymic hsd nude mice xenograft for PLC cell line5.0E+6 pfuReduction in tumor volume below 2000mm compared to control after 45 days No responseNAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2064Vaccinia virusGLV-1h68DNAPoxviridaeNoneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANANANANAAthymic hsd nude mice xenograft for PLC cell line5.0E+6 pfuReduction in tumor volume below 3000mm compared to control after 35 days NAInduction of apoptosis in cancer cell lineIncreased expression of immunological gene such as GM-CSF, IFN-gamma, IL-6,2,12,18, IP-10, MCP-1,3,5, TNF-alpha and MIP-2NA21779374
OV_2412Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman colorectal cancer cell lineHCT-83.0E+4 cells per wellNALDH release and spectrophometer0.01 MOINo cell killing after day 1NoNoNA No responseNANANANA22258815
OV_2413Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman colorectal cancer cell lineHCT-83.0E+4 cells per wellNALDH release and spectrophometer0.01 MOINo cell killing after day 3NoNoNA No responseNANANANA22258815
OV_2414Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman colorectal cancer cell lineHCT-83.0E+4 cells per wellNALDH release and spectrophometer0.01 MOINo cell killing after day 5NoNoNA No responseNANANANA22258815
OV_2415Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman colorectal cancer cell lineHCT-83.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI50% cell killing after day 7NoNoNA No responseNANANANA22258815
OV_2416Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman colorectal cancer cell lineHCT-83.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI40% cell survival after day 9NoNoNA No responseNANANANA22258815
OV_2417Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2418Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2419Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI90% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2420Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI20% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2421Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell killing after day 9NoNoNA No responseNANANANA22258815
OV_2422Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman gastric cancer cell lineMKN-453.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2423Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman gastric cancer cell lineMKN-453.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2424Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman gastric cancer cell lineMKN-453.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2425Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman gastric cancer cell lineMKN-453.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 7NoNoNA No responseNANANANA22258815
OV_2426Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman gastric cancer cell lineMKN-453.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 9NoNoNA No responseNANANANA22258815
OV_2427Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman squamous cell lineSCC-253.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2428Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman squamous cell lineSCC-253.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2429Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman squamous cell lineSCC-253.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2430Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman squamous cell lineSCC-253.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI50% cell killing after day 7NoNoNA No responseNANANANA22258815
OV_2431Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman squamous cell lineSCC-253.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI60% cell killing after day 9NoNoNA No responseNANANANA22258815
OV_2432Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman mesothelia cell lineMSTO-2113.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2433Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman mesothelia cell lineMSTO-2113.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2434Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman mesothelia cell lineMSTO-2113.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2435Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman mesothelia cell lineMSTO-2113.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI50% cell killing after day 7NoNoNA No responseNANANANA22258815
OV_2436Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman mesothelia cell lineMSTO-2113.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI60% cell killing after day 9NoNoNA No responseNANANANA22258815
OV_2437Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman lung cancer cell lineH16503.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2438Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman lung cancer cell lineH16503.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2439Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman lung cancer cell lineH16503.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI90% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2440Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman lung cancer cell lineH16503.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI90% cell survival after day 7NoNoNA No responseNANANANA22258815
OV_2441Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman lung cancer cell lineH16503.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI80% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2442Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2443Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2444Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2445Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 7NoNoNA No responseNANANANA22258815
OV_2446Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman breast cancer cell lineMDA-MB-2313.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 9NoNoNA No responseNANANANA22258815
OV_2447Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman thyroid cancer cell line8505c3.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2448Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman thyroid cancer cell line8505c3.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI100% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2449Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman thyroid cancer cell line8505c3.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI90% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2450Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman thyroid cancer cell line8505c3.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI60% cell survival after day 7NoNoNA No responseNANANANA22258815
OV_2451Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman thyroid cancer cell line8505c3.0E+4 cells per wellNALDH release and spectrophometer0.01 MOI10% cell survival after day 9NoNoNA No responseNANANANA22258815
OV_2452Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman colorectal cancer cell lineHCT-83.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2453Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman colorectal cancer cell lineHCT-83.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI100% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2454Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman colorectal cancer cell lineHCT-83.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI100% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2455Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman colorectal cancer cell lineHCT-83.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI70% cell survival after day 7NoNoNA No responseNANANANA22258815
OV_2456Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman colorectal cancer cell lineHCT-83.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI30% cell survival after day 7NoNoNA No responseNANANANA22258815
OV_2457Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2458Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI90% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2459Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI50% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2460Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI10% cell survival after day 7NoNoNA No responseNANANANA22258815
OV_2461Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI100% cell death after day 9NoNoNA No responseNANANANA22258815
OV_2462Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman gastric cancer cell lineMKN-453.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2463Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman gastric cancer cell lineMKN-453.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI100% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2464Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman gastric cancer cell lineMKN-453.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI100% cell survival after day 5NoNoNA No responseNANANANA22258815
OV_2465Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman gastric cancer cell lineMKN-453.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI100% cell survival after day 7NoNoNA No responseNANANANA22258815
OV_2466Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman gastric cancer cell lineMKN-453.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI80% cell survival after day 9NoNoNA No responseNANANANA22258815
OV_2467Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman squamous cell lineSCC-253.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI100% cell survival after day 1NoNoNA No responseNANANANA22258815
OV_2468Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman squamous cell lineSCC-253.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI90% cell survival after day 3NoNoNA No responseNANANANA22258815
OV_2469Vaccinia virusGLV-1h151DNAPoxviridaeDeteltion of TK gene and addition of GFP geneYesNoNoATCCHuman squamous cell lineSCC-253.0E+4 cells per wellNALDH release and spectrophometer0.10 MOI50% cell survival after day 5NoNoNA No responseNANANANA22258815